Month: September 2026

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:	Rathbones Group Plc
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	NextEnergy Solar Fund Ltd
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e)   Date position held/dealing undertaken:         For an opening position disclosure, state the latest practicable date prior to the disclosure	10/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?         If it is a cash offer or possible cash offer, state “N/A”	No

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	Ordinary NPV
	Interests		Short positions
	Number	%	Number	%
(1)   Relevant securities owned and/or controlled:	5,966,409	1.03%
(2)   Cash-settled derivatives:
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:	5,966,409	1.03%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit
Ordinary NPV	Sale	30,000	49.8182p

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
Ordinary NPV

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)   the voting rights of any relevant securities under any option; or (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:	11/09/2026
Contact name:	Callum Ridley – Compliance Department
Telephone number:	0151 243 7037

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

The Pioneer in Clean Nail Care is Coming to One of Fairfield County’s Most Anticipated New Destinations

DARIEN, CT, Sept. 11, 2026 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (“MiniLuxe” or the “Company”), a purpose-driven beauty and self-care brand redefining the nail and waxing experience through clean products, ethical and empowering employment practices, and elevated service standards, today announced that their Strategic Growth Partner Vera Vos-Lexmond has signed a lease for the brand’s first Connecticut location within The Corbin District in downtown Darien. The studio is the first of multiple locations Vos Lexmond has committed to developing across Fairfield County, CT with an opening targeted for early 2027.

Developed by Baywater Properties on seven acres in the heart of downtown Darien, The Corbin District is reimagining the center of town with top culinary talent, high-end boutiques, luxury residential units, and office spaces arranged around a vibrant new town square. Among its confirmed tenants are consulting firm McKinsey & Co., Aon Financial Services, Yoga Spark, Barry’s Bootcamp, Rhone, Millie’s Restaurant from Nantucket, Connecticut’s first Tatte Bakery & Café, and Corsica, a new restaurant from the team behind Barcelona Wine Bar. The Corbin District’s development team has been highly selective in its leasing strategy, seeking out businesses that align with Darien and Fairfield County’s lifestyle, demographics, and long-term growth. For developer David Genovese, MiniLuxe represents exactly the kind of tenant that vision was designed to attract where experience, as much as convenience, matters.

MiniLuxe was founded on the conviction that the nail salon industry was overdue for a fundamental reinvention and a purpose anchored in providing empowerment and joy to its team, clients and communities. MiniLuxe’s studios use only better-for-you, non-toxic products, maintain rigorous hygiene and sterilization protocols, and invest in training and fairly compensating the nail artists who deliver the experience. Since its founding, the company has paid more than $200M in fair wages to its designers with over half holding equity options in the business.

“MiniLuxe and The Corbin District share the same north star,” said David Genovese, CEO of Baywater Properties and developer of The Corbin District. “We are both committed to bringing something genuinely better to Darien. When we set out to build this district, our goal was to create a walkable, beautiful downtown destination with tenants that reflect the community’s standards and aspirations. MiniLuxe is exactly the kind of brand we had in mind, and we are proud to welcome them as part of what we are building here together.”

The Darien announcement also marks a strategic milestone in MiniLuxe’s national franchise and joint venture (JV) expansion. With over 25 opened studios and strong inbound franchise interest since its program’s launch, MiniLuxe is building a model that scales without compromising the standards that make it distinctive. Connecticut, positioned as a natural bridge between MiniLuxe’s New England base and the New York metropolitan market, is expected to become one of the brand’s most significant growth territories.

“Connecticut has always been central to our growth vision,” said Tony Tjan, Co-Founder and CEO of MiniLuxe. “Fairfield County reflects the same customer sophistication and values-driven consumer that helped us build a loyal following across New England. Opening inside The Corbin District gives us the ideal platform to introduce MiniLuxe to Connecticut in a setting that shares our commitment to quality, community, and intentional design. We are building something much larger here, and Darien is where that next chapter begins.”

“I fell in love with MiniLuxe because it stands for everything I believe beauty should be,” said Vera Vos-Lexmond, “high standards, real transparency, and a genuine commitment to the people doing the work. Fairfield County is my home, and I wanted to bring a brand here that my community would be proud to have. The Corbin District is exactly the kind of environment where MiniLuxe belongs, surrounded by great food, thoughtful retail, and neighbors who care deeply about quality. I cannot wait to open our doors.”

MiniLuxe remains actively in conversation with prospective franchise partners across key metropolitan corridors and welcomes inquiries from qualified operators interested in joining its growing network. Consumers eager to be among the first to experience MiniLuxe in Connecticut can follow updates at miniluxe.com and on social media.

About MiniLuxe

MiniLuxe Holding Corp. is a Boston-based lifestyle brand and talent empowerment platform transforming the fragmented beauty and self-care industry through its premium service brand, proprietary products, and operating platform. For more than 15 years, MiniLuxe has delivered high-quality nail care, waxing, and esthetic services through a growing network of company-owned, joint venture, and partner-operated studios, completing more than 5 million services to date.

The Company is recognized for its elevated service experience, rigorous hygiene standards, non-toxic products, modern studio design, and commitment to socially responsible labor practices. MiniLuxe’s differentiated model is designed to create better outcomes for both clients and beauty professionals through career development, economic mobility, equity participation, and future ownership opportunities.

MiniLuxe is expanding its reach through a multi-pronged growth strategy that includes new studio development, franchising, and the acquisition and conversion of existing nail salons. By combining a trusted consumer brand, proprietary products, operating expertise, and technology-enabled systems, the Company offers entrepreneurs and operators the opportunity to partner with a proven platform while preserving a strong focus on talent development and service excellence.

Through its growing studio network and product portfolio, MiniLuxe seeks to build the leading trusted brand in beauty and self-care while generating long-term value for clients, talent, and shareholders.

Media Contact
MiniLuxe Marketing & Communications
cmastrangelo@miniluxe.com
www.miniluxe.com

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:	Rathbones Group Plc
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree	Eleco Plc
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e)   Date position held/dealing undertaken:         For an opening position disclosure, state the latest practicable date prior to the disclosure	10/09/2026
(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?         If it is a cash offer or possible cash offer, state “N/A”	No

2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	1p Ordinary Shares
	Interests		Short positions
	Number	%	Number	%
(1)   Relevant securities owned and/or controlled:	1,167,650	1.38%
(2)   Cash-settled derivatives:
(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:	1,167,650	1.38%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)      Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit
1p Ordinary Shares	Sale	1,050	229.038p

(b)        Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit

(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
1p Ordinary Shares

4.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)   the voting rights of any relevant securities under any option; or (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:	11/09/2026
Contact name:	Callum Ridley – Compliance Department
Telephone number:	0151 243 7037

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the H.C. Wainwright 28^th Annual Global Investment Conference, taking place in New York City September 14-16, 2026.

On Wednesday, September 16, 2026, at 10:30 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, Charles Morris, MBChB, MRCP. Chief Medical Officer, Peggy Scherle, Ph.D., Chief Scientific Officer, and Bryant Lim, Chief Financial Officer will participate in a fireside chat.

A live webcast of the fireside chat can be accessed on the Company’s website under Events and Presentations. The recording will be archived and available on the Company’s website for 90 days.

About Prelude Therapeutics
Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and JAK2V617F mutant selective inhibitors — new approaches to clinically validated targets with transformative potential for patients. We are leveraging our expertise in targeted protein degradation to create and develop next generation degrader antibody conjugates (DACs) with novel payloads. We are on a mission to extend the promise of precision medicine to every cancer patient in need. For more information, visit preludetx.com.

Investor Contact: 
Robert Doody
Senior Vice President, Investor Relations 
Prelude Therapeutics
484.639.7235
RDoody@preludetx.com

CALGARY, Alberta, Sept. 11, 2026 (GLOBE NEWSWIRE) — Capital Power and Alpine Canada, joined by the Government of Canada, will make a major announcement on Friday, September 11, on the future of Canadian winter sport.

The announcement will include remarks from Avik Dey, President & CEO, Capital Power; Andrew Baker, incoming President & CEO, Alpine Canada; and the Honourable Adam van Koeverden, Secretary of State (Sport).

Members of Canada’s National Ski Team will be in attendance including Cameron Alexander, Olympian, World Championships bronze medalist, Kitzbühel World Cup third place finisher; Reece Howden, 2x Olympian, 4x Crystal Globe winner, all-time ski cross leader with 24 World Cup wins; and Kalle Eriksson, 3-time Paralympic medalist.

A media availability and photo opportunity will follow.

Date: Friday, September 11, 2026

Time: Media check-in: 3:00 PM MT; Remarks and announcement: 3:30 PM MT

Location: WinSport, 88 Canada Olympic Road S.W., Calgary, Alberta, T3B 5R5

Announcement to be held on the second floor of the WinSport Day Lodge; please park in the Day Lodge parking lot and enter through the main doors near the east end of the building and check in with staff at the front entrance of the facility for access.

Members of the media are asked to RSVP to Capital Power Media Relations at kperron@capitalpower.com to confirm their attendance and receive further information, as needed.

Contacts
Katherine Perron
Capital Power
kperron@capitalpower.com

Mark Halliday
Alpine Canada
media@alpinecanada.org

Bahoz Dara Aziz
Office of the Secretary of State (Sport)
Bahoz.daraaziz@pch.gc.ca